IN8BIO INC (INAB) Stock Income Statement
NASDAQ:INAB - Nasdaq - US45674E1091 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 27.38M | 29.60M | 30.34M | 28.52M | 14.65M | |||
| Research and Development | 15.03M | 16.96M | 16.83M | 14.06M | 7.35M | |||
| Selling, General, and Administrative Expenses | 12.35M | 12.64M | 13.51M | 14.46M | 7.31M | |||
| Operating Income | -27.38M | -29.60M | -30.34M | -28.52M | -14.65M | |||
| Interest Income/Expense | 257.00K | 230.00K | N/A | N/A | N/A | |||
| Other Income/Expense | N/A | 0.00 | 330.00K | N/A | N/A | |||
| Non Recurring Items | N/A | -1.07M | N/A | N/A | N/A | |||
| Income Before Taxes | -27.43M | -30.44M | -30.01M | -28.52M | -14.65M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Net Income | -27.43M | -30.44M | -30.01M | -28.52M | -14.65M | |||
| EBITDA | -25.50M | -27.76M | -28.50M | -27.91M | -14.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -14.60 | -17.05 | -30.14 | -40.80 | -23.40 | |||
| Non GAAP EPS | -13.50 | -17.40 | -30.30 | -42.60 | N/A | |||
| Statistics | ||||||||
All data in USD